March 06, 2015 7:03 AM ET

Biotechnology

Company Overview of Agouron Pharmaceuticals, Inc.

Executive Profile

Michael D. Varney Ph.D.

Head of Genentech Research & Early Development, Roche Holding AG
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 4 different industries.

See Board Relationships
56--

Background

Mr. Michael D. Varney, also known as Mike, Ph.D. has been Head of Genentech Research & Early Development at Roche Holding AG since January 1, 2015. Mr. Varney served as Head of Small Molecule Drug Discovery and Co-Head of Genentech Research at Roche Holding AG until December 31, 2014. Mr. Varney served as Senior Vice President of Small Molecule Drug Discovery at Genentech Inc. He joined Agouron Pharmaceuticals, Inc. in 1987 and served as its Vice President of Research ...

Corporate Headquarters

10777 Science Center Drive
San Diego, California 92121-1111

United States

Phone: 858-622-3000
Fax: 858-678-8267

Board Members Memberships

There is no Board Members Memberships data available.

Education

Doctorate
California Institute of Technology
PhD
California Institute of Technology
BS
University of California-Los Angeles

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
$3.2M
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
$1.5M
Serge Weinberg Chairman, Interim Chief Executive Officer, Chairman of Appointments & Governance Committee and Chairman of Strategy Committee
Sanofi
$700.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Agouron Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.